Project Details
| Status | Finished |
|---|---|
| Effective start/end date | 4/17/14 → 1/31/18 |
Funding
- Medpace, Inc. (ALN-TTR02-004 // ALN-TTR02-004)
- Alnylam Pharmaceuticals, Inc. (ALN-TTR02-004 // ALN-TTR02-004)
ALN-TTR02-004 – “APOLLO: A Phase 3 Multicenter, Multinational, Randomized, Double-blind, Placebo-controlled Study to Evaluate the Efficacy and Safety of ALN-TTR02 in Transthyretin (TTR)-Mediated Polyneuropathy (Familial Amyloidotic Polyneuropathy-FAP)”
- Ajroud-Driss, Senda (PD/PI)
Project: Research project